Pedro R. Cutillas
Charterhouse Square
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 128 publications
The AGO2 adaptor LIMD1 expands the functional and evolutionary reach of microRNA targeting.
Journal: Science advances
Published: July 23, 2026
PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer.
Journal: Cell reports
Published: June 04, 2026
Quantitative phosphoproteomics uncovers the signalling dynamics of hallucinogenic psychedelics.
Journal: bioRxiv : the preprint server for biology
Published: December 15, 2025
Surfaceome Capture by Multiplex Biotinylation Enables Enhanced Identification of Cell Surface Proteins by Mass Spectrometry.
Journal: Molecular & cellular proteomics : MCP
Published: November 25, 2025
The Src inhibitor peptide TAT-Cx43266-283 improves survival in an intracranial murine model of lung cancer brain metastasis.
Journal: Neuro-oncology advances
Published: November 24, 2025
PERK orchestrates an endoplasmic reticulum stress alternative splicing program via CLK1/SRSF1.
Journal: Nature communications
Published: October 17, 2025
Glycosylated extracellular matrix drives immune suppression by modulating macrophage-T cell crosstalk in triple-negative breast cancer.
Journal: Nature communications
Published: August 14, 2025
Functional Pathway Inference Analysis (FPIA).
Journal: Methods in molecular biology (Clifton, N.J.)
Published: August 08, 2025
Understanding the sources of performance in deep drug response models reveals insights and improvements.
Journal: Bioinformatics (Oxford, England)
Published: July 15, 2025
Replication origin firing capacity indicates ATR inhibitor sensitivity.
Journal: Nature communications
Published: March 10, 2025
Last Updated: 09/26/2026